Essential Hypertension
Conditions
Interventions
This is a randomized controlled clinical study. The sample will be 20 sedentary elderly hypertensive women. The Intervention Group (IG) will be made up of 10 sedentary hypertensive elderly women and t
G11.427.410.698.277
Sponsors
Universidade de Passo Fundo
Universidade Regional Integrada do Alto Uruguai e das Missões
Eligibility
Sex/Gender
Female
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Being female. Be aged 60 or over. Have the ability to walk. Be sedentary according to the World Health Organization WHO 2018 classification practicing less than 150 minutes of moderate physical exercise per week. Have a previous diagnosis of hypertension, have been using antihypertensive medication for at least three months and are not in a hypertensive crisis Systolic Blood Pressure SBP maior que 180 milímetros de mercúrio mmHg and Diastolic Blood Pressure DBP maior que 120 milímetros de mercúrio mmHg. Present a preserved cognitive aspect, according to the results of the Montreal Cognitive Assessment - MoCA above 26 points. Participants who do not reach the minimum score will normally participate in the study, but will not be included in the data analysis
Exclusion criteria
Exclusion criteria: Inability to communicate with investigators. Present a high risk of deep vein thrombosis. Grade II and III obesity Body mass index BMI=35 kg/m2. Participants who do not achieve 75% attendance at meetings. Patients with a cardiac pacemaker. Present depressive symptoms (above 6 points) according to the results of the geriatric depression scale (GDS-15). Have a previous diagnosis of oncological, rheumatological, cardiovascular diseases (except SAH), kidney disease resulting from Systemic Arterial Hypertension - SAH or with cardiovascular, neurological, psychiatric and/or cognitive, immunological and hematological repercussions. Patient on continuous use of hypoglycemic medications. Patients with reduced mobility (range of movement)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a difference in improving muscle strength, balance, maintenance of heart rate and blood pressure, as well as an increase in BDNF levels and modulation of inflammatory mediators. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactFabrízzio Pelle Perez
Universidade de Passo Fundo
Outcome results
None listed